Open Access

Role of chlorhexidine gluconate in ventilator-associated pneumonia prevention strategies in ICU patients: where are we headed?

Critical Care200913:427

https://doi.org/10.1186/cc8165

Published: 27 November 2009

We read with interest the recent study by Scannapieco and colleagues [1], which concluded that twice-daily oral rinse with 0.12% chlorhexidine failed to reduce the number of potential respiratory pathogens in dental plaque, mortality, the incidence of ventilator-associated pneumonia (VAP), the length of intensive care unit (ICU) stay and the duration of mechanical ventilation in trauma ICU patients.

Trauma ICU patients are similar to mixed ICU patients with respect to risk factors for developing VAP, unlike patients undergoing elective cardiac surgery. Use of 0.12% chlorhexidine decreases the incidence of VAP in patients undergoing elective cardiac surgery. In mixed ICU patients, chlorhexidine at concentrations less than 0.2% has consistently been shown to have no benefit [2]. A randomized trial using 2% chlorhexidine has, however, demonstrated a reduction in VAP rates in these patients [3]. A previous study showed that 12-hourly application of chlorhexidine has a sustained preventive effect on biofilm formation [4]. The lack of benefit from twice-daily oral cleansing with chlorhexidine in the present study may be due to the lower concentration of chlorhexidine.

The authors' recommendation for investigation into mechanical plaque removal with chlorhexidine would conceptually have some added benefit. Mechanical plaque removal with chlorhexidine, however, has not affected outcomes in ICU patients in two studies [5, 6].

We therefore suggest that further studies using oral chlorhexidine in ICU patients should be conducted using higher concentrations (2%) to test the most appropriate frequency of use, since oral cleansing is a nursing-driven intervention and clinical trials with chlorhexidine are yet to demonstrate a mortality benefit.

Abbreviations

ICU: 

intensive care unit

VAP: 

ventilator-associated pneumonia.

Declarations

Authors’ Affiliations

(1)
Department of Medicine, University of Louisville School of Medicine, ACB
(2)
Department of Neurology, Case Western Reserve University School of Medicine

References

  1. Scannapieco FA, Yu J, Raghavendran K, Vacanti A, Owens SI, Wood K, Mulotte JM: A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit Care 2009, 13: R117. 10.1186/cc7967PubMed CentralView ArticlePubMedGoogle Scholar
  2. Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM, Karnad DR: Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open label randomized trial with 0.01% potassium permanganate as control. Chest 2009, 135: 1150-1156. 10.1378/chest.08-1321View ArticlePubMedGoogle Scholar
  3. Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V: Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2008, 29: 131-136. 10.1086/526438View ArticlePubMedGoogle Scholar
  4. Sekino S, Ramberg P, Uzel NG, Socranksky S, Lidhe J: The effect of a chlorhexidine regimen on de novo plaque formation. J Clin Periodontol 2004, 31: 609-614. 10.1111/j.1600-051X.2004.00526.xView ArticlePubMedGoogle Scholar
  5. Pobo A, Lisboa T, Rodriguez A, Sloe R, Margret M, Trefler S, Gomez F, Rello J: A randomized trial of dental brushing for preventing ventilator associated pneumonia. Chest 2009, 136: 433-439. 10.1378/chest.09-0706View ArticlePubMedGoogle Scholar
  6. Munro CL, Grap MJ, Jones DJ, McClish DK, Sessler CN: Chlorhexidine, toothbrushing and preventing ventilator-associated pneumonia in critically ill adults. Am J Crit Care 2009, 18: 428-437. 10.4037/ajcc2009792PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd 2009

Advertisement